(Q43574350)

24 November 2017

Release and aggregation of cytochrome c and alpha-synuclein are inhibited by the antiparkinsonian drugs, talipexole and pramipexole (English)

1 reference

24 November 2017

1 reference

Kakimura J

1

1 reference

24 November 2017

Kitamura Y

2

1 reference

24 November 2017

Takata K

3

1 reference

24 November 2017

Kohno Y

4

1 reference

24 November 2017

Nomura Y

5

1 reference

24 November 2017

Taniguchi T

6

1 reference

24 November 2017

language of work or name

English

0 references

publication date

1 April 2001

1 reference

European Journal of Pharmacology

24 November 2017

1 reference

24 November 2017

417

1 reference

24 November 2017

1-2

1 reference

24 November 2017

59-67

1 reference

Glycoxidation and oxidative stress in Parkinson disease and diffuse Lewy body disease.

24 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900902-5

Synucleins in synaptic plasticity and neurodegenerative disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900902-5

Stabilization of alpha-synuclein secondary structure upon binding to synthetic membranes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900902-5

Chronic parkinsonism secondary to intravenous injection of meperidine analogues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900902-5

7 January 2021

From entropy to Duino

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900902-5

MPP+ produces progressive neuronal degeneration which is mediated by oxidative stress.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900902-5

A Drosophila model of Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900902-5

Apomorphine enantiomers protect cultured pheochromocytoma (PC12) cells from oxidative stress induced by H2O2 and 6-hydroxydopamine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900902-5

Parkinson's disease: prospects for improved drug therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900902-5

Caspase-3: A vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900902-5

Alpha-synuclein in Lewy body disease and Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900902-5

Role of cytochrome c as a stimulator of alpha-synuclein aggregation in Lewy body disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900902-5

The precursor protein of non-A beta component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900902-5

Enhanced vulnerability to oxidative stress by alpha-synuclein mutations and C-terminal truncation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900902-5

Inhibitory effects of talipexole and pramipexole on MPTP-induced dopamine reduction in the striatum of C57BL/6N mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900902-5

Protective effect of talipexole on MPTP-treated planarian, a unique parkinsonian worm model.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900902-5

Protective effects of the antiparkinsonian drugs talipexole and pramipexole against 1-methyl-4-phenylpyridinium-induced apoptotic death in human neuroblastoma SH-SY5Y cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900902-5

The parkinsonian models: invertebrates to mammals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900902-5

Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900902-5

Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900902-5

Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900902-5

The parkinsonism-inducing drug 1-methyl-4-phenylpyridinium triggers intracellular dopamine oxidation. A novel mechanism of toxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900902-5

Distinct mechanisms underlie neurotoxin-mediated cell death in cultured dopaminergic neurons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900902-5

Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900902-5

Membrane association and protein conformation of alpha-synuclein in intact neurons. Effect of Parkinson's disease-linked mutations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900902-5

Deficiencies in complex I subunits of the respiratory chain in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900902-5

Purification and characterization of a novel brain-specific 14-kDa protein.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900902-5

Etiology and pathogenesis of Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900902-5

Self-oligomerization of NACP, the precursor protein of the non-amyloid beta/A4 protein (A beta) component of Alzheimer's disease amyloid, observed in the presence of a C-terminal A beta fragment (residues 25-35).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900902-5

Mitochondrial complex I deficiency in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900902-5

Fiber diffraction of synthetic alpha-synuclein filaments shows amyloid-like cross-beta conformation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900902-5

alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900902-5

Evidence for generation of oxidative stress in brain by MPTP: in vitro and in vivo studies in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900902-5

Cloning and characterization of the cDNA encoding a novel brain-specific 14-kDa protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900902-5

Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900902-5

Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900902-5

10.1016/S0014-2999(01)00902-5

7 January 2021

Identifiers

DOI

1 reference

24 November 2017

1 reference